Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17,000
Frequently Asked Questions
What is Market Cap of Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC market cap is $35.31B.
What is the 52-week high for Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC 52 week high is $31.80 as of April 06, 2026.
What is the 52-week low for Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC 52 week low is $20.08 as of April 06, 2026.
What is Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price today?
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price today is $28.69.
What was Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price yesterday?
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price yesterday was $27.70.
What is the PE ratio of Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC's P/E ratio is 3.01.
What is the Price-to-Book ratio of Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC P/B ratio is 1.1341.
What is the 50-day moving average of Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC 50-day moving average is $29.51.
How many employees does Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC have?
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC has 17,000 employees.